These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23751357)

  • 21. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
    González F
    Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
    Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.
    Wang Y; Zhang WY; Hu S; Lan F; Lee AS; Huber B; Lisowski L; Liang P; Huang M; de Almeida PE; Won JH; Sun N; Robbins RC; Kay MA; Urnov FD; Wu JC
    Circ Res; 2012 Dec; 111(12):1494-503. PubMed ID: 22967807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.
    Şişli HB; Hayal TB; Seçkin S; Şenkal S; Kıratlı B; Şahin F; Doğan A
    Adv Exp Med Biol; 2020; 1237():17-28. PubMed ID: 31728915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precise and efficient scarless genome editing in stem cells using CORRECT.
    Kwart D; Paquet D; Teo S; Tessier-Lavigne M
    Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering.
    Sackett SD; Rodriguez A; Odorico JS
    Rev Diabet Stud; 2017; 14(1):39-50. PubMed ID: 28632820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming to pluripotency: from frogs to stem cells.
    Rossant J
    Cell; 2009 Sep; 138(6):1047-50. PubMed ID: 19766555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular Diseases.
    Chun YW; Durbin MD; Hong CC
    Curr Cardiol Rep; 2018 Apr; 20(6):38. PubMed ID: 29666931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human pluripotent stem cell based islet models for diabetes research.
    Balboa D; Otonkoski T
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):899-909. PubMed ID: 26696518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling Cancer with Pluripotent Stem Cells.
    Gingold J; Zhou R; Lemischka IR; Lee DF
    Trends Cancer; 2016 Sep; 2(9):485-494. PubMed ID: 27722205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome engineering of stem cell organoids for disease modeling.
    Sun Y; Ding Q
    Protein Cell; 2017 May; 8(5):315-327. PubMed ID: 28102490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technological overview of iPS induction from human adult somatic cells.
    Bayart E; Cohen-Haguenauer O
    Curr Gene Ther; 2013 Apr; 13(2):73-92. PubMed ID: 23320476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncoding RNAs in the Regulation of Pluripotency and Reprogramming.
    Sherstyuk VV; Medvedev SP; Zakian SM
    Stem Cell Rev Rep; 2018 Feb; 14(1):58-70. PubMed ID: 29143182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient scarless genome editing in human pluripotent stem cells.
    Ikeda K; Uchida N; Nishimura T; White J; Martin RM; Nakauchi H; Sebastiano V; Weinberg KI; Porteus MH
    Nat Methods; 2018 Dec; 15(12):1045-1047. PubMed ID: 30504872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Back to the future: how human induced pluripotent stem cells will transform regenerative medicine.
    Svendsen CN
    Hum Mol Genet; 2013 Oct; 22(R1):R32-8. PubMed ID: 23945396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
    Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
    [No Abstract]   [Full Text] [Related]  

  • 39. Induced pluripotent stem cell technology in regenerative medicine and biology.
    Pei D; Xu J; Zhuang Q; Tse HF; Esteban MA
    Adv Biochem Eng Biotechnol; 2010; 123():127-41. PubMed ID: 20549468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells.
    Nakamura M; Okano H
    Cell Res; 2013 Jan; 23(1):70-80. PubMed ID: 23229514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.